Josee Guindon, DVM, PhD of Texas Tech University Health Sciences Center, was named as the recipient for this award, which recognizes dedication, perseverance, and skill in studying and researching the endocannabinoid system.
In early January, Texas Tech University Health Sciences Center (TTUHSC) announced that researcher and associate professor Josee Guindon, DVM, PhD, had been chosen to receive the international William A. Devane Young Investigator Award from the International Cannabinoid Research Society (ICRS). Dr. Guindon will receive the award at the ICRS’s 33rd Annual International Cannabinoid Research Society Symposium June 24–29, 2023 in Toronto, Canada.
“It's quite a diverse field that has been booming extensively and a lot of National Institute of Health (NIH) funding is put toward cannabinoids because of its legalization across many states now,” said Dr. Guindon (1). “Basically, it’s medicinal versus recreational that are the main focus, but a lot of studies now are trying to improve our understanding about the physiological effects of cannabinoids across different disciplines.”
According to TTUHSC’s announcement, three of Dr. Guindon’s most recent peer-reviewed publications demonstrated the role of sex hormones and cannabinoids in pain, in modulating breast and ovarian cancer tumor growth, and how cannabinoids influence ovarian tumor growth (1).